North American Graves’ disease Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2025
North American Graves’ disease market is growing at a CAGR of around 4.3% during the forecast period. North American Grave’s disease market has been primarily driven by increasing prevalence of thyroid disorders, and significant awareness about thyroid treatment and diagnosis. Moreover, some initiatives to support Americans suffering from thyroid disease are also contributing to the growth of the North American Graves’ disease market. For instance, in January 2016, AmeriCares supported thousands of Americans suffering from thyroid disease in terms of providing medication. This donation was conducted in recognition of Thyroid Awareness Month. This will enable health and emergency response organizations to offer levothyroxine therapy for an average 25,000 underinsured, insured, and low-income patients of community health centers and clinics nationwide.
To Request a Sample of our Report on North
American Graves’ disease Market: https://www.omrglobal.com/request-sample/north-american-graves-disease-market
According to the American Thyroid
Association, approximately 20 million people all over the US have some kind of
thyroid disorders. Several patients require medication to control the
functioning of the thyroid and needs treatment for life. Akrimax
Pharmaceuticals, LLC, located in Cranford, New Jersey, US is a key sponsor of
the thyroid month campaign. The company donated $2.4 million worth of
levothyroxine therapy. This is sufficient to meet monthly prescriptions for
approximately 25,000 patients.
Due to significant rise in the
prevalence of thyroid disorders, the increasing number of smokers, the
considerable population suffering from type-1 diabetes and launching of thyroid
awareness programs by pharmaceutical companies in North America. The North
American Graves’ disease market has been estimated to grow at a CAGR of 4.3%
during the forecast period of 2018-2023. The US is the leading shareholder in
the North American Grave’s diseases market. Substantial funding for R&D
activities in the US is also contributing towards the North American Graves’
disease during the forecast period.
(Get 15% Discount on
Buying this Report)
A
full Report of North American Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/north-american-graves-disease-market
North American Graves’ disease Market Segmentation
By Diagnosis
·
Ultrasound
·
Imaging Tests
·
Radioactive Iodine Uptake
·
Blood Sample
By Treatment
·
Anti- Thyroid Medication
·
Radioactive Iodine Therapy
·
Surgery
Regional Analysis
·
United States
·
Canada
Company Profiles
·
Abbott Laboratories Inc.
·
Allergan PLC
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Macleods Pharmaceuticals Ltd.
·
Merck & Co. Inc.
·
Mylan NV
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment